Xtant Medical Holdings, Inc. (XTNT) stock
XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3080% below fair value
$0.21−0.00 (-2.19%)
Close on Nov 17, 2026Market cap $28.79MP/E –Yield –
Xtant Medical revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Xtant Medical's revenue for the twelve months ending Jun 30, 2026 was $109.53M, down 14.3% year over year. For fiscal 2025 it was $133.93M, up 14.2% from the year before. Over ten years it grew 8.5% a year on average. The highest annual figure on record is $133.93M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $133.93M | +14.2% |
| FY2024 | Dec 31, 2024 | $117.27M | +28.4% |
| FY2023 | Dec 31, 2023 | $91.30M | +57.5% |
| FY2022 | Dec 31, 2022 | $57.97M | +4.9% |
| FY2021 | Dec 31, 2021 | $55.26M | +3.6% |
| FY2020 | Dec 31, 2020 | $53.34M | -17.5% |
| FY2019 | Dec 31, 2019 | $64.68M | -10.4% |
| FY2018 | Dec 31, 2018 | $72.20M | -12.6% |
| FY2017 | Dec 31, 2017 | $82.61M | -8.2% |
| FY2016 | Dec 31, 2016 | $90.00M | +51.7% |
| FY2015 | Dec 31, 2015 | $59.35M | +68.0% |
| FY2014 | Dec 31, 2014 | $35.33M | +6.8% |
| FY2013 | Dec 31, 2013 | $33.07M | +0.3% |
| FY2012 | Dec 31, 2012 | $32.98M | +9.4% |
| FY2011 | Dec 31, 2011 | $30.15M | +95.6% |
| FY2010 | Dec 31, 2010 | $15.42M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $23.03M | -35.0% |
| Q1 FY2026 | Mar 31, 2026 | $20.88M | -36.5% |
| Q4 FY2025 | Dec 31, 2025 | $32.36M | +2.7% |
| Q3 FY2025 | Sep 30, 2025 | $33.26M | +19.0% |
| Q2 FY2025 | Jun 30, 2025 | $35.41M | +18.3% |
| Q1 FY2025 | Mar 31, 2025 | $32.90M | +18.0% |
| Q4 FY2024 | Dec 31, 2024 | $31.51M | +12.1% |
| Q3 FY2024 | Sep 30, 2024 | $27.94M | +11.7% |
| Q2 FY2024 | Jun 30, 2024 | $29.94M | +48.0% |
| Q1 FY2024 | Mar 31, 2024 | $27.87M | +55.3% |
| Q4 FY2023 | Dec 31, 2023 | $28.11M | +84.1% |
| Q3 FY2023 | Sep 30, 2023 | $25.02M | +73.0% |
| Q2 FY2023 | Jun 30, 2023 | $20.23M | +32.4% |
| Q1 FY2023 | Mar 31, 2023 | $17.94M | +38.5% |
| Q4 FY2022 | Dec 31, 2022 | $15.27M | +9.3% |
| Q3 FY2022 | Sep 30, 2022 | $14.46M | +5.0% |
| Q2 FY2022 | Jun 30, 2022 | $15.28M | +2.0% |
| Q1 FY2022 | Mar 31, 2022 | $12.96M | +3.3% |
| Q4 FY2021 | Dec 31, 2021 | $13.97M | -0.3% |
| Q3 FY2021 | Sep 30, 2021 | $13.78M | -1.7% |
| Q2 FY2021 | Jun 30, 2021 | $14.98M | +42.2% |
| Q1 FY2021 | Mar 31, 2021 | $12.54M | -15.1% |
| Q4 FY2020 | Dec 31, 2020 | $14.02M | -17.4% |
| Q3 FY2020 | Sep 30, 2020 | $14.02M | -10.8% |
| Q2 FY2020 | Jun 30, 2020 | $10.53M | -31.1% |
| Q1 FY2020 | Mar 31, 2020 | $14.78M | -11.6% |
| Q4 FY2019 | Dec 31, 2019 | $16.96M | -7.1% |
| Q3 FY2019 | Sep 30, 2019 | $15.72M | -8.9% |
| Q2 FY2019 | Jun 30, 2019 | $15.27M | -18.5% |
| Q1 FY2019 | Mar 31, 2019 | $16.73M | -6.7% |
| Q4 FY2018 | Dec 31, 2018 | $18.26M | -5.5% |
| Q3 FY2018 | Sep 30, 2018 | $17.27M | -12.7% |
| Q2 FY2018 | Jun 30, 2018 | $18.74M | -12.5% |
| Q1 FY2018 | Mar 31, 2018 | $17.93M | -18.8% |
| Q4 FY2017 | Dec 31, 2017 | $19.33M | -21.0% |
| Q3 FY2017 | Sep 30, 2017 | $19.79M | -14.3% |
| Q2 FY2017 | Jun 30, 2017 | $21.41M | – |
| Q1 FY2017 | Mar 31, 2017 | $22.08M | – |
| Q4 FY2016 | Dec 31, 2016 | $24.47M | – |
| Q3 FY2016 | Sep 30, 2016 | $23.09M | – |
See a number that looks wrong?